Anticorps Monoclonal anti-Ki-67
Ki-67 Monoclonal Antibody for IHC, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
IHC, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1B9H2
N° de cat : 66555-6-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66555-6-PBS cible Ki-67 dans les applications de IHC, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | Ki-67 Protéine recombinante Ag26266 |
Nom complet | antigen identified by monoclonal antibody Ki-67 |
Masse moléculaire calculée | 359 kDa |
Numéro d’acquisition GenBank | NM_002417 |
Symbole du gène | KI67 |
Identification du gène (NCBI) | 4288 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
The Ki-67 protein (also known as MKI67) is a cellular marker for proliferation. Ki67 is present during all active phases of the cell cycle (G1, S, G2 and M), but is absent in resting cells (G0). Cellular content of Ki-67 protein markedly increases during cell progression through S phase of the cell cycle. Therefore, the nuclear expression of Ki67 can be evaluated to assess tumor proliferation by immunohistochemistry. It has been demonstrated to be of prognostic value in breast cancer. In head and neck cancer, several studies have reported an association between high proliferative activity and poorer prognosis.